




Searching News Database: Estradiol Transdermal
HSMN NewsFeed - 29 Sep 2014
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
HSMN NewsFeed - 21 Nov 2011
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
HSMN NewsFeed - 29 Apr 2008
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
HSMN NewsFeed - 19 Dec 2006
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
HSMN NewsFeed - 25 Jul 2006
Mylan Announces Final Approval for Additional Strengths of Estradiol Transdermal Systems
Mylan Announces Final Approval for Additional Strengths of Estradiol Transdermal Systems
HSMN NewsFeed - 4 Jan 2006
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
FDA Approves Osteoporosis Indication for Once-a-Week Hormone Therapy Patch, Climara Pro(R)
Additional items found! 16

Members Archive contains
16 additional stories matching:
Estradiol Transdermal
(Password required)
Estradiol Transdermal
(Password required)